Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANDU PHARMA vs SUVEN PHARMACEUTICALS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANDU PHARMA SUVEN PHARMACEUTICALS SANDU PHARMA/
SUVEN PHARMACEUTICALS
 
P/E (TTM) x 48.8 46.4 105.1% View Chart
P/BV x 1.4 9.9 14.2% View Chart
Dividend Yield % 1.3 0.9 147.4%  

Financials

 SANDU PHARMA   SUVEN PHARMACEUTICALS
EQUITY SHARE DATA
    SANDU PHARMA
Mar-23
SUVEN PHARMACEUTICALS
Mar-23
SANDU PHARMA/
SUVEN PHARMACEUTICALS
5-Yr Chart
Click to enlarge
High Rs86629 13.7%   
Low Rs50388 13.0%   
Sales per share (Unadj.) Rs67.652.7 128.5%  
Earnings per share (Unadj.) Rs1.616.2 9.7%  
Cash flow per share (Unadj.) Rs2.118.0 11.7%  
Dividends per share (Unadj.) Rs0.756.00 12.5%  
Avg Dividend yield %1.11.2 93.3%  
Book value per share (Unadj.) Rs40.668.2 59.6%  
Shares outstanding (eoy) m9.66254.57 3.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.09.7 10.4%   
Avg P/E ratio x43.331.5 137.6%  
P/CF ratio (eoy) x32.328.2 114.6%  
Price / Book Value ratio x1.77.5 22.5%  
Dividend payout %47.637.1 128.3%   
Avg Mkt Cap Rs m658129,395 0.5%   
No. of employees `000NANA-   
Total wages/salary Rs m1111,105 10.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m65313,403 4.9%  
Other income Rs m3464 0.7%   
Total revenues Rs m65713,867 4.7%   
Gross profit Rs m255,739 0.4%  
Depreciation Rs m5477 1.1%   
Interest Rs m1128 0.6%   
Profit before tax Rs m225,597 0.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m71,484 0.5%   
Profit after tax Rs m154,113 0.4%  
Gross profit margin %3.842.8 8.9%  
Effective tax rate %31.426.5 118.4%   
Net profit margin %2.330.7 7.6%  
BALANCE SHEET DATA
Current assets Rs m25511,554 2.2%   
Current liabilities Rs m1393,031 4.6%   
Net working cap to sales %17.863.6 28.1%  
Current ratio x1.83.8 48.3%  
Inventory Days Days65148 43.6%  
Debtors Days Days268302 88.6%  
Net fixed assets Rs m2869,547 3.0%   
Share capital Rs m97255 38.0%   
"Free" reserves Rs m29617,097 1.7%   
Net worth Rs m39217,352 2.3%   
Long term debt Rs m046 0.0%   
Total assets Rs m54221,101 2.6%  
Interest coverage x28.744.7 64.2%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.20.6 189.9%   
Return on assets %3.020.1 14.7%  
Return on equity %3.923.7 16.3%  
Return on capital %5.932.9 17.8%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m014,672 0.0%   
Fx outflow Rs m01,848 0.0%   
Net fx Rs m012,824 0.0%   
CASH FLOW
From Operations Rs m24,509 0.0%  
From Investments Rs m5-1,948 -0.3%  
From Financial Activity Rs m6-2,358 -0.2%  
Net Cashflow Rs m13202 6.6%  

Share Holding

Indian Promoters % 42.9 9.9 433.3%  
Foreign collaborators % 0.0 50.1 -  
Indian inst/Mut Fund % 0.0 26.1 0.0%  
FIIs % 0.0 10.1 -  
ADR/GDR % 0.0 0.0 -  
Free float % 57.1 40.0 142.8%  
Shareholders   10,021 70,052 14.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANDU PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on SANDU PHARMA vs SUVEN PHARMACEUTICALS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

SANDU PHARMA vs SUVEN PHARMACEUTICALS Share Price Performance

Period SANDU PHARMA SUVEN PHARMACEUTICALS S&P BSE HEALTHCARE
1-Day -0.45% 5.78% 1.18%
1-Month -15.08% 5.21% -0.75%
1-Year 9.73% 44.00% 61.82%
3-Year CAGR 19.30% 12.19% 18.16%
5-Year CAGR 21.14% 32.13% 19.79%

* Compound Annual Growth Rate

Here are more details on the SANDU PHARMA share price and the SUVEN PHARMACEUTICALS share price.

Moving on to shareholding structures...

The promoters of SANDU PHARMA hold a 42.9% stake in the company. In case of SUVEN PHARMACEUTICALS the stake stands at 60.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of SANDU PHARMA and the shareholding pattern of SUVEN PHARMACEUTICALS.

Finally, a word on dividends...

In the most recent financial year, SANDU PHARMA paid a dividend of Rs 0.8 per share. This amounted to a Dividend Payout ratio of 47.6%.

SUVEN PHARMACEUTICALS paid Rs 6.0, and its dividend payout ratio stood at 37.1%.

You may visit here to review the dividend history of SANDU PHARMA, and the dividend history of SUVEN PHARMACEUTICALS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.